These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 9001699)

  • 21. Nifedipine potentiates the antinociceptive effect of endomorphin-1 microinjected into the periaqueductal gray in rats.
    Cousins MJ; Hao S; Mamiya K; Takahata O; Iwasaki H; Mata M; Fink DJ
    Anesth Analg; 2003 Apr; 96(4):1065-1071. PubMed ID: 12651662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrathecal beta-funaltrexamine antagonizes intracerebroventricular beta-endorphin- but not morphine-induced analgesia in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1988 May; 245(2):587-93. PubMed ID: 2966856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Forebrain sites differentially sensitive to beta-endorphin and morphine for analgesia and release of Met-enkephalin in the pentobarbital-anesthesized rat.
    Tseng LF; Wang Q
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1028-36. PubMed ID: 1318368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of delta opioid receptors in the ventrolateral periaqueductal gray region inhibits the fall in arterial pressure evoked by hemorrhage.
    Cavun S; Resch GE; Evec AD; Rapacon-Baker MM; Millington WR
    J Pharmacol Exp Ther; 2001 May; 297(2):612-9. PubMed ID: 11303050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of spinal opioid antinociception by intrathecal beta-endorphin1-27 in the rat.
    Hong M; Sutak M; Jhamandas K
    Br J Pharmacol; 1993 Apr; 108(4):1137-42. PubMed ID: 8485623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repetitive exposure to the hot-plate test produces stress induced analgesia and alters beta-endorphin neuronal transmission within the periaqueductal gray of the rat.
    Hawranko AA; Monroe PJ; Smith DJ
    Brain Res; 1994 Dec; 667(2):283-6. PubMed ID: 7697368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of neurotensin in the nucleus raphe magnus in opioid-induced antinociception from the periaqueductal gray.
    Urban MO; Smith DJ
    J Pharmacol Exp Ther; 1993 May; 265(2):580-6. PubMed ID: 8496808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (+)-Morphine and (-)-morphine stereoselectively attenuate the (-)-morphine-produced tail-flick inhibition via the naloxone-sensitive sigma receptor in the ventral periaqueductal gray of the rat.
    Terashvili M; Wu HE; Moore RM; Harder DR; Tseng LF
    Eur J Pharmacol; 2007 Sep; 571(1):1-7. PubMed ID: 17597599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of GABA receptor antagonists injected spinally on antinociception induced by opioids administered supraspinally in mice.
    Suh HW; Kim YH; Choi YS; Choi SR; Song DK
    Eur J Pharmacol; 1996 Jun; 307(2):141-7. PubMed ID: 8832215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antinociception produced by 14,15-epoxyeicosatrienoic acid is mediated by the activation of beta-endorphin and met-enkephalin in the rat ventrolateral periaqueductal gray.
    Terashvili M; Tseng LF; Wu HE; Narayanan J; Hart LM; Falck JR; Pratt PF; Harder DR
    J Pharmacol Exp Ther; 2008 Aug; 326(2):614-22. PubMed ID: 18492947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antinociception from the administration of beta-endorphin into the periaqueductal gray of rat is enhanced while that of morphine is inhibited by barbiturate anesthesia.
    Smith DJ; Robertson B; Monroe PJ
    Neurosci Lett; 1992 Nov; 146(2):143-6. PubMed ID: 1491780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antinociception produced by mu opioid receptor activation in the amygdala is partly dependent on activation of mu opioid and neurotensin receptors in the ventral periaqueductal gray.
    Tershner SA; Helmstetter FJ
    Brain Res; 2000 May; 865(1):17-26. PubMed ID: 10814729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal effect and analgesia: evidence for different involvement of opioid receptor subtypes in periaqueductal gray matter.
    Parolaro D; Crema G; Sala M; Santagostino A; Giagnoni G; Gori E
    Eur J Pharmacol; 1986 Jan; 120(1):95-9. PubMed ID: 2868906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lesions of the periaqueductal gray disrupt input to the rostral ventromedial medulla following microinjections of morphine into the medial or basolateral nuclei of the amygdala.
    McGaraughty S; Farr DA; Heinricher MM
    Brain Res; 2004 May; 1009(1-2):223-7. PubMed ID: 15120601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-endorphin-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats.
    Silva RM; Hadjimarkou MM; Rossi GC; Pasternak GW; Bodnar RJ
    J Pharmacol Exp Ther; 2001 May; 297(2):590-6. PubMed ID: 11303047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naloxone blocks opioid peptide release in N. accumbens and amygdala elicited by morphine injected into periaqueductal gray.
    Ma QP; Shi YS; Han JS
    Brain Res Bull; 1992 Feb; 28(2):351-4. PubMed ID: 1596757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microinjection of morphine into various amygdaloid nuclei differentially affects nociceptive responsiveness and RVM neuronal activity.
    McGaraughty S; Heinricher MM
    Pain; 2002 Mar; 96(1-2):153-62. PubMed ID: 11932071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
    Abul-Husn NS; Sutak M; Milne B; Jhamandas K
    Br J Pharmacol; 2007 Jul; 151(6):877-87. PubMed ID: 17502848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.